TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY PRODUCT
6.1. Overview
6.2. Estrogen & Progesterone Replacement Therapy
6.3. HGH Replacement Therapy
6.4. Thyroid Hormone Replacement Therapy
6.5. Parathyroid Hormone Replacement
7. GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION
7.1. Overview
7.2. Oral
7.3. Parenteral
7.4. Transdermal
7.5. Others
8. GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY DISEASE TYPE
8.1. Overview
8.2. Menopause
8.3. Hypothyroidism
8.4. Male Hypogonadism
9. GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY REGION
9.1. Overview
9.1. North America
9.1.1. US
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. France
9.2.3. UK
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. India
9.3.3. Japan
9.3.4. South Korea
9.3.5. Australia
9.3.6. Rest of Asia-Pacific
9.4. Rest of the World
9.4.1. Middle East
9.4.2. Africa
9.4.3. Latin America
10. COMPETITIVE LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the Global Hormone replacement therapy Market,
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the Global Hormone replacement therapy Market,
10.7. Key developments and Growth Strategies
10.7.1. New Product Launch/Service Deployment
10.7.2. Merger & Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix
10.8.1. Sales & Operating Income, 2022
10.8.2. Major Players R&D Expenditure. 2022
11. COMPANY PROFILES
11.1. Bayer AG
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Products Offered
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Pfizer Inc
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Products Offered
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. Merck & Co., Inc
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Products Offered
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. Viatris Inc
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Products Offered
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. Novo Nordisk A/S
11.5.1. Company Overview
11.5.2. Financial Overview
11.5.3. Products Offered
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. Eli Lilly and Company
11.6.1. Company Overview
11.6.2. Financial Overview
11.6.3. Products Offered
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. F. Hoffmann-La Roche Ltd
11.7.1. Company Overview
11.7.2. Financial Overview
11.7.3. Products Offered
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. Noven Pharmaceuticals Inc
11.8.1. Company Overview
11.8.2. Financial Overview
11.8.3. Products Offered
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. Ascend Therapeutics Us, LLC
11.9.1. Company Overview
11.9.2. Financial Overview
11.9.3. Products Offered
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. AbbVie Inc
11.10.1. Company Overview
11.10.2. Financial Overview
11.10.3. Products Offered
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.10.6. Key Strategies
12. APPENDIX
12.1. References
12.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL HORMONE REPLACEMENT THERAPY MARKET, SYNOPSIS, 2018-2032
TABLE 2 GLOBAL HORMONE REPLACEMENT THERAPY MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)
TABLE 3 GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 4 GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 5 GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 6 NORTH AMERICA: HORMONE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 7 NORTH AMERICA: HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 8 NORTH AMERICA: HORMONE REPLACEMENT THERAPY MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 9 US: HORMONE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 10 US: HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 11 US: HORMONE REPLACEMENT THERAPY MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 12 CANADA: HORMONE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 13 CANADA: HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 14 CANADA: HORMONE REPLACEMENT THERAPY MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 1 EUROPE: HORMONE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 2 EUROPE: HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 3 EUROPE: HORMONE REPLACEMENT THERAPY MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 4 GERMANY: HORMONE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 5 GERMANY: HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 6 GERMANY: HORMONE REPLACEMENT THERAPY MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 7 FRANCE: HORMONE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 8 FRANCE: HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 9 FRANCE: HORMONE REPLACEMENT THERAPY MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 10 ITALY: HORMONE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 11 ITALY: HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 12 ITALY: HORMONE REPLACEMENT THERAPY MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 13 SPAIN: HORMONE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 14 SPAIN: HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 15 SPAIN: HORMONE REPLACEMENT THERAPY MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 16 UK: HORMONE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 17 UK: HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 18 UK: HORMONE REPLACEMENT THERAPY MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 19 REST OF EUROPE: HORMONE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 20 REST OF EUROPE: HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 21 REST OF EUROPE: HORMONE REPLACEMENT THERAPY MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 22 ASIA-PACIFIC: HORMONE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 23 ASIA-PACIFIC: HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 24 ASIA-PACIFIC: HORMONE REPLACEMENT THERAPY MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 25 JAPAN: HORMONE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 26 JAPAN: HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 27 JAPAN: HORMONE REPLACEMENT THERAPY MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 28 CHINA: HORMONE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 29 CHINA: HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 30 CHINA: HORMONE REPLACEMENT THERAPY MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 31 INDIA: HORMONE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 32 INDIA: HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 33 INDIA: HORMONE REPLACEMENT THERAPY MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 34 AUSTRALIA: HORMONE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 35 AUSTRALIA: HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 36 AUSTRALIA: HORMONE REPLACEMENT THERAPY MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 37 SOUTH KOREA: HORMONE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 38 SOUTH KOREA: HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 39 SOUTH KOREA: HORMONE REPLACEMENT THERAPY MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 40 REST OF ASIA-PACIFIC: HORMONE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 41 REST OF ASIA-PACIFIC: HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 42 REST OF ASIA-PACIFIC: HORMONE REPLACEMENT THERAPY MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 43 REST OF THE WORLD: HORMONE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 44 REST OF THE WORLD: HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 45 REST OF THE WORLD: HORMONE REPLACEMENT THERAPY MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 46 MIDDLE EAST: HORMONE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 47 MIDDLE EAST: HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 48 MIDDLE EAST: HORMONE REPLACEMENT THERAPY MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 49 AFRICA: HORMONE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 50 AFRICA: HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 51 AFRICA: HORMONE REPLACEMENT THERAPY MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 52 LATIN AMERICA: HORMONE REPLACEMENT THERAPY MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 53 LATIN AMERICA: HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 54 LATIN AMERICA: HORMONE REPLACEMENT THERAPY MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL HORMONE REPLACEMENT THERAPY MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL HORMONE REPLACEMENT THERAPY MARKET
FIGURE 4 GLOBAL HORMONE REPLACEMENT THERAPY MARKET, SHARE (%), BY PRODUCT, 2022
FIGURE 5 GLOBAL HORMONE REPLACEMENT THERAPY MARKET, SHARE (%), BY ROUTE OF ADMINISTRATION, 2022
FIGURE 6 GLOBAL HORMONE REPLACEMENT THERAPY MARKET, SHARE (%), BY DISEASE TYPE, 2022
FIGURE 7 GLOBAL HORMONE REPLACEMENT THERAPY MARKET, SHARE (%), BY REGION, 2022
FIGURE 8 NORTH AMERICA: HORMONE REPLACEMENT THERAPY MARKET, SHARE (%), BY REGION, 2022
FIGURE 9 EUROPE: HORMONE REPLACEMENT THERAPY MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 ASIA-PACIFIC: HORMONE REPLACEMENT THERAPY MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 REST OF THE WORLD: HORMONE REPLACEMENT THERAPY MARKET, SHARE (%), BY REGION, 2022
FIGURE 12 GLOBAL HORMONE REPLACEMENT THERAPY MARKET: COMPANY SHARE ANALYSIS, 2022 (%)
FIGURE 13 BAYER AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 BAYER AG: SWOT ANALYSIS
FIGURE 15 PFIZER INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 PFIZER INC: SWOT ANALYSIS
FIGURE 17 MERCK & CO,. INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 MERCK & CO,. INC: SWOT ANALYSIS
FIGURE 19 VIATRIS INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 VIATRIS INC: SWOT ANALYSIS
FIGURE 21 NOVO NORDISK A/S: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 NOVO NORDISK A/S: SWOT ANALYSIS
FIGURE 23 ELI LILLY AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 ELI LILLY AND COMPANY: SWOT ANALYSIS
FIGURE 25 F. HOFFMANN-LA ROCHE LTD: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 F. HOFFMANN-LA ROCHE LTD: SWOT ANALYSIS
FIGURE 27 NOVEN PHARMACEUTICALS INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 NOVEN PHARMACEUTICALS INC: SWOT ANALYSIS
FIGURE 29 ASCEND THERAPEUTICS US, LLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 ASCEND THERAPEUTICS US, LLC: SWOT ANALYSIS
FIGURE 31 ABBVIE INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 ABBVIE INC: SWOT ANALYSIS
